Paul M. Szabolcs
Experienced in Systemic Sclerosis (SSc)

Dr. Paul M. Szabolcs

Pediatric Hematology Oncology
UPMC
BMT At Pediatric Hematology Oncology In Lawrenceville
4401 Penn Avenue, 
Pittsburgh, PA 
On Staff At
Clinical Trials:Currently Recruiting for 2 Trials
35 Years of Experience

Experienced in Systemic Sclerosis (SSc)
UPMC
BMT At Pediatric Hematology Oncology In Lawrenceville
4401 Penn Avenue, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Paul Szabolcs, MD, received his medical degree summa cum laude at the Semmelweis University School of Medicine in Budapest, Hungary. He completed his training in pediatrics at Bellevue Hospital/NYU Medical Center and subsequently trained in hematology/oncology at the Memorial Sloan Kettering Cancer Center/Cornell-NY Hospital Medical Center in New York City. He received postdoctoral laboratory training at the Memorial Sloan Kettering Cancer Center and at Rockefeller University in the Department of Physiology and Cellular Immunology.

Dr. Szabolcs is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Systemic Sclerosis (SSc), Delayed Growth, Infantile Neutropenia, and Wildervanck Syndrome.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NC
Fellowships
Memorial Sloan-Kettering Cancer Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 6 Less Insurance Carriers -

Locations

BMT at Pediatric Hematology Oncology in Lawrenceville
4401 Penn Avenue, Pittsburgh, PA 15224
Call: 412-692-5055

Additional Areas of Focus

Dr. Szabolcs has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation
A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation
Enrollment Status: Recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drugs: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa
Study Phase: Phase 2
Lung Transplant in Tandem with Bone Marrow Transplant for Combined Lung and Bone Marrow Failure
Lung Transplant in Tandem with Bone Marrow Transplant for Combined Lung and Bone Marrow Failure
Enrollment Status: Recruiting
Publish Date: January 09, 2025
Intervention Type: Drug, Biological
Study Drugs: CD3/CD19 negative hematopoietic stem cells, Rituximab, Alemtuzumab, Fludarabine, Thiotepa, G-CSF, Hydroxyurea
Study Phase: Phase 1/Phase 2
A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants With Severe Combined Immunodeficiency (SCID) Receiving TCRαβ+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC)
A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants With Severe Combined Immunodeficiency (SCID) Receiving TCRαβ+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC)
Enrollment Status: Active_not_recruiting
Publish Date: November 21, 2025
Intervention Type: Drug, Device
Study Drug: Busulfan
Study Phase: Phase 2
Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA Matched Cadaveric Donors (RTB-003)
Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA Matched Cadaveric Donors (RTB-003)
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug, Other
Study Drug: Omidubicel
Study Phase: Phase 3
View 3 Less Clinical Trials

34 Total Publications

Prophylactic high-dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation.
Prophylactic high-dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation.
Journal: Vox sanguinis
Published: February 04, 2025
View All 34 Publications
Similar Doctors
Paulina Horvei
Experienced in Systemic Sclerosis (SSc)
Dr. Paulina Horvei
Pediatric Hematology Oncology
Experienced in Systemic Sclerosis (SSc)
Dr. Paulina Horvei
Pediatric Hematology Oncology

BMT At Pediatric Hematology Oncology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances

Paulina Horvei, MD, is board-certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh. Dr. Horvei received her medical degree from the University of Chile and completed her residency at Icahn School of Medicine at Mount Sinai, followed by fellowships at Mayo Clinic College of Medicine and Science and the University of California San Francisco School of Medicine. Dr. Horvei is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Systemic Sclerosis (SSc) and Immune Thrombocytopenic Purpura (ITP).

VIEW MORE SYSTEMIC SCLEROSIS (SSC) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Szabolcs's expertise for a condition
ConditionClose
        • Experienced
        • Beta-Mannosidosis
          Dr. Szabolcs is
          Experienced
          . Learn about Beta-Mannosidosis.
          See more Beta-Mannosidosis experts
        • CHARGE Syndrome
          Dr. Szabolcs is
          Experienced
          . Learn about CHARGE Syndrome.
          See more CHARGE Syndrome experts
        • Chediak-Higashi Syndrome
          Dr. Szabolcs is
          Experienced
          . Learn about Chediak-Higashi Syndrome.
          See more Chediak-Higashi Syndrome experts
        • Delayed Growth
          Dr. Szabolcs is
          Experienced
          . Learn about Delayed Growth.
          See more Delayed Growth experts
        • Early Infantile Epileptic Encephalopathy
          Dr. Szabolcs is
          Experienced
          . Learn about Early Infantile Epileptic Encephalopathy.
          See more Early Infantile Epileptic Encephalopathy experts
        • Infantile Neutropenia
          Dr. Szabolcs is
          Experienced
          . Learn about Infantile Neutropenia.
          See more Infantile Neutropenia experts
        View All 10 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Patient Details

          This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.